首页> 美国卫生研究院文献>PLoS Clinical Trials >Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

【2h】

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

机译：在开始抗逆转录病毒治疗后存活了十年的HIV阳性患者的特定病因死亡率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo estimate mortality rates and prognostic factors in HIV-positive patients who started combination antiretroviral therapy between 1996–1999 and survived for more than ten years.

机译：目的评估1996-1999年间开始联合抗逆转录病毒疗法并存活超过十年的HIV阳性患者的死亡率和预后因素。

著录项

期刊名称 PLoS Clinical Trials
作者
Adam Trickey; Margaret T. May; Janne Vehreschild; Niels Obel; Michael John Gill; Heidi Crane; Christoph Boesecke; Hasina Samji; Sophie Grabar; Charles Cazanave; Matthias Cavassini; Leah Shepherd; Antonella d’Arminio Monforte; Colette Smit; Michael Saag; Fiona Lampe; Vicky Hernando; Marta Montero; Robert Zangerle; Amy C. Justice; Timothy Sterling; Jose Miro; Suzanne Ingle; Jonathan A. C. Sterne;
展开▼
作者单位

展开▼
年(卷),期 2011(11),8
年度 2011
页码 e0160460
总页数 16
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs [J] . Nosyk Bohdan, Min Jeong E., Evans Elizabeth, Clinical infectious diseases . 2015,第7期

机译：阿片类药物替代治疗和高效抗逆转录病毒疗法对注射毒品的HIV阳性人群中特定原因的死亡率风险的影响
2. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs [J] . Nosyk Bohdan, Min Jeong E., Evans Elizabeth, Clinical infectious diseases . 2015,第7期

机译：阿片类替代治疗和高活性抗逆转录病毒治疗对注射药物的艾滋病毒阳性人民死亡率的归因特异性风险
3. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study [J] . May Margaret T., Vehreschild Jorg-Janne, Trickey Adam, Clinical infectious diseases . 2016,第12期

机译：在开始治疗后长达15年的HIV感染患者联合抗逆转录病毒治疗开始时根据CD4计数的死亡率：协作队列研究
4. The Effectiveness of Antiretroviral Therapy in Observed HIV-Positive population (Gdansk, Poland) [C] . M. Lemanska, M. Jankowska, T. Smiatacz International AIDS Conference . 2004

机译：抗逆转录病毒治疗在观察到的艾滋病毒阳性群体中的有效性（Gdansk，波兰）
5. Menopausal Hormone Therapy Use, Urinary Estrogen Metabolites, and Long-Term All-Cause and Cause-Specific Mortality Following Breast Cancer [D] . Wang, Tengteng. 2019

机译：更年期激素治疗使用，尿道雌激素代谢物和长期全因和造成特异性死亡率后乳腺癌
6. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study [O] . Margaret T. May, Jorg-Janne Vehreschild, Adam Trickey, -1

机译：在开始治疗后长达15年的HIV感染患者联合抗逆转录病毒治疗开始时根据CD4计数的死亡率：协作队列研究
7. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy. [O] . Trickey, A., May, M.T., Vehreschild, J., 2016

机译：在开始抗逆转录病毒疗法后存活了十年的HIV阳性患者的特定病因死亡率。

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

摘要

著录项

相似文献

相关主题

期刊订阅